Healthcare & Biotech

Delray Beach, Fla. – September 08, 2026 -- The global Dental Service Organization (DSO) market is projected to climb to USD 303.32 billion by 2031 from USD 199.88 billion in 2026, a compound annual growth rate of 8.7%, according to MarketsandMarkets.

North America leads as dentist affiliation with DSOs accelerates

North America held the largest regional share in 2025, driven by an established DSO ecosystem, a high concentration of multi-location dental practices, and rising dentist affiliation with DSO networks. Growth is further fueled by administrative complexity, staffing shortages at independent practices, and increased dental care spending.

Westport, Conn. – September 08, 2026 -- Pink Aid, the sole national nonprofit providing emergency financial aid to breast cancer patients, has launched the 'Visionary Circle,' a corporate advisory group aimed at expanding its national reach and fundraising capacity.

Breast cancer treatment drains $3.14 billion annually from U.S. patients

Out-of-pocket costs for breast cancer care can exceed $100,000 per year for some families, according to Pink Aid. Roughly one in three patients faces severe financial hardship during treatment, a figure that climbs to 78% among patients in low- and middle-income communities.

Pink Aid has distributed $6 million to 9,200 patients since 2015

The organization partners with more than 1,200 hospital social workers across 400 hospitals nationwide, delivering emergency funds within 48 hours to cover rent, utilities, groceries, and transportation costs during active treatment.

Stuttgart – September 08, 2026 -- Pharma Deutschland's Baden-Württemberg chapter and MEDIVERBUND AG kicked off development of a regional action plan aimed at strengthening self-medication as a lever to relieve pressure on doctors' offices and build a more resilient healthcare system.

Industry and physician groups agree self-medication can free up doctor capacity

At the "Selbstverständlich Selbstmedikation" event, representatives from politics, medicine, pharmacies, health insurers and the pharmaceutical industry discussed conditions needed to expand patient self-treatment for minor ailments. Dr. Traugott Ullrich, chairman of Pharma Deutschland's Baden-Württemberg association, argued that low-threshold self-medication allows patients to treat or prevent minor health issues while pharmacies handle counseling and physicians retain capacity for more complex cases.

Burlington, Mass. – September 08, 2026 -- Azenta, Inc. (Nasdaq: AZTA) has received full repayment, ahead of maturity, of a $35 million secured vendor loan tied to its divestiture of B Medical Systems S.à r.l., closing out the transaction with the entire $63 million purchase price now collected in cash.

Azenta collects $35 million vendor loan before maturity

Azenta Germany GmbH, a wholly owned subsidiary, had extended the secured term loan to buyer Thelema S.à r.l. as part of the sale that closed July 1, 2026. The loan was secured by a pledge over B Medical Systems' equity interests. Thelema repaid the principal along with all accrued interest, and Azenta released the share pledge that secured the debt.

Total cash proceeds reach $63 million

With the vendor loan settled, Azenta has now received the full $63 million purchase price for B Medical Systems in cash, eliminating the credit exposure the company carried since the deal closed.

Macau – September 08, 2026 -- Global eye care nonprofit Orbis International has launched its first-ever simulation-based training project in Macau, marking 20 years of local partnership that has raised more than US$33 million for the organization's work in China and worldwide.

Orbis brings 70 clinicians from eight Chinese hospitals for Flying Eye Hospital training

The project engages 70 ophthalmologists and nurses from eight Orbis partner hospitals across China, who will receive advanced training and mentorship aboard the Flying Eye Hospital aircraft and at Kiang Wu Nursing College of Macau. Training covers simulated cataract, glaucoma, strabismus, medical retina, and nursing specialties. Orbis states these professionals collectively serve more than 245,000 patients annually in China.

Fort Lauderdale – – September 08, 2026 -- KIC Ventures issued a corporate clarification confirming that the U.S. Department of Justice dismissed all criminal charges against portfolio company SpineFrontier Inc. on January 17, 2025, and that no current KIC Ventures portfolio company faces ongoing DOJ litigation tied to the matter.

DOJ moved to dismiss all criminal charges against SpineFrontier in January 2025.

The company stated that no KIC Ventures portfolio entity pleaded guilty to any criminal charge arising from the case and that none remains a defendant in related federal litigation. KIC Ventures said it issued the reminder because customers, physicians and investors may still encounter older reports referencing the original allegations without the case's subsequent dismissal.

Fort Washington, Pa. – September 08, 2026 -- ECRI, a global authority on healthcare safety and quality, has appointed Professor Najmedin Meshkati, PhD, to its Board of Trustees, bringing nearly four decades of complex-systems safety research from aviation, nuclear power, and petrochemical operations to the nonprofit's patient safety mission.

Meshkati investigated the world's most scrutinized industrial disasters

Professor Meshkati has examined the BP Texas City Refinery explosion, the Deepwater Horizon oil spill, and the Fukushima Daiichi nuclear disaster. He testified before the U.S. Senate Committee on Commerce, Science, and Transportation as a member of the FAA's independent Expert Panel on Boeing, which reviewed the company's safety management system and safety culture. He currently chairs the State of California's Diablo Canyon Independent Safety Committee.

Shanghai – September 08, 2026 -- Pulnovo Medical's pulmonary artery denervation (PADN) system reduced the risk of clinical worsening by 51% in patients with pulmonary hypertension linked to left heart disease (PH-LHD), according to results from the PADN-HF-PH trial presented at the European Society of Cardiology (ESC) Congress 2026 and simultaneously published in The New England Journal of Medicine.

Trial enrolled 264 patients across multiple centers under academician Yaling Han

The multicenter, randomized controlled study, led by academician Yaling Han of the General Hospital of Northern Theater Command, evaluated PADN as an add-on to guideline-directed medical therapy (GDMT) versus GDMT alone. Corresponding authors on the NEJM paper include Professor Shao-Liang Chen of Nanjing First Hospital and Professor Gregg W. Stone of Mount Sinai Hospital.

Washington – September 08, 2026 -- Independent testing commissioned by the Alliance to Prevent Legionnaires' Disease (APLD) found Legionella bacteria in 17 percent of 109 water samples collected from sinks, showers, hose bibs and other fixtures across the Upper East Side outbreak zone, results the group says expose gaps in New York City's current prevention strategy.

Testing detected live, culturable Legionella pneumophila serogroup 1 across all three sampled zip codes

The independent consultant collected samples in mid-July across zip codes 10128, 10028 and 10075, the area the City identified as the outbreak zone. Legionella was found in 19 buildings, including 10 exterior hose bibs, seven sinks, one shower and a decorative fountain. Positive samples showed Legionella concentrations ranging from less than 1 to 390 CFU/mL, with Legionella pneumophila serogroup 1 confirmed in all three zip codes.

Boston – September 08, 2026 -- TraceLink has integrated its Drug Supply Chain Security Act (DSCSA) compliance solution with Omnicell, Inc. (Nasdaq: OMCL) pharmacy inventory management systems, embedding serialized product verification and traceability directly into hospital medication receiving workflows.

Integration eliminates separate compliance tools during medication receiving

Hospital and health system pharmacies must currently verify, document, and incorporate medication shipments into inventory while resolving compliance exceptions through manual processes that run alongside operational systems. The new integration allows pharmacy teams to verify serialized products, access traceability data, resolve verification exceptions, and complete compliance reporting within Omnicell's central pharmacy inventory management workflows as medications are received.